MPT-0-L-145

N/A

Report date: 2022/06/07 17:25:28
NME

Base Information

Drug NameMPT-0-L-145
Drug Alias NameMPT-0-L-145MPT0L145
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptors antagonistsPhosphatidylinositol 3-kinase catalytic subunit type 3 inhibitors
TargetsFibroblast growth factor receptorsPhosphatidylinositol 3-kinase catalytic subunit type 3
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTaipei Medical University
China Registration ClassN/A

Develop Information

Active CompaniesTaipei Medical University
Inactive CompaniesN/A
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A